Navigation Links
Novo Nordisk Increased Operating Profit by 11% in the First Nine Months of 2007 Based on a 9% Sales Increase and an Improved Gross Margin
Date:10/31/2007

PRINCETON, N.J., Oct. 31 /PRNewswire-FirstCall/ -- Novo Nordisk (NYSE: NVO), a global healthcare company, today released its financial statement for the period January 1, 2007 to September 30, 2007.

-- Novo Nordisk increased sales by 14% in local currencies and by 9% in

Danish kroner due to a significant negative currency development.

-- Sales of modern insulins increased by 37% (31% in Danish kroner).

-- Sales of NovoSeven(R) increased by 10% (4% in Danish kroner).

-- Sales of Norditropin(R) increased by 12% (7% in Danish kroner).

-- Sales in North America increased by 25% (15% in Danish kroner).

-- Gross margin increased to 76.7% in the first nine months of 2007 up

from 75.2% in the same period last year, primarily reflecting continued

productivity improvements.

-- Operating profit increased by 11% to USD 1,410 million. Adjusted for

the impact from currencies, underlying operating profit increased by

more than 20%.

-- Net profit increased by 60% to USD 1,361 million, primarily reflecting

the divestment of Dako's business activities in the second quarter of

2007. Earnings per share (diluted) increased by 62% to USD 4.26.

-- The expectation for full-year sales growth is still 11-14% measured in

local currencies and now 6-9% as reported due to the depreciation of

key invoicing currencies. Full-year operating profit growth remains

unchanged around 20% measured in local currencies and is now expected

to be close to 10% as reported.

-- In October, Novo Nordisk received marketing authorization for

Levemir(R) in Japan for both type 1 and type 2 diabetes including

combination treatment with oral antidiabetics.

Lars Rebien Sorensen, president and CEO, said "Our portfolio of modern insulins continues to show strong sales growth in all key markets. Within the next few months we will be launching Levemir(R) in FlexPen(R) in Japan, which will further support growth in the coming years."

* For convenience, Danish kroner has been translated to USD in this release, using the average exchange rate of USD 1.00 = DKK 5.54317.

Novo Nordisk is a healthcare company with an 84-year history of innovation and achievement in diabetes care. The company has the broadest diabetes product portfolio in the industry, including the most advanced products within the area of insulin delivery systems.In addition to diabetes care, Novo Nordisk has a leading position within areas such as hemostasis management, growth hormone therapy, and hormone therapy for women. Novo Nordisk's business is driven by the Triple Bottom Line: a commitment to economic success, environmental soundness, and social responsibility to employees and customers. With headquarters in Denmark, Novo Nordisk employs more than 23,600 employees in 79 countries, and markets its products in 179 countries. Novo Nordisk's B shares are listed on the stock exchanges in Copenhagen and London. Its ADRs are listed on the New York Stock Exchange under the symbol 'NVO'. For global information, visit novonordisk.com; for United States information, visit novonordisk-us.com.


'/>"/>
SOURCE Novo Nordisk
Copyright©2007 PR Newswire.
All rights reserved

Related biology technology :

1. cMaster RTplusPCR System for increased sensitivity and product length in RT-PCR
2. Increased Sensitivity in Microarray Analysis
3. Increased Transfer Efficiency Using a Discontinuous Buffer System With the Trans-Blot SD Cell
4. Increased Analyte Sensitivity through the Utility of Enhanced Mass-Resolution on the FinniganTSQ Quantum Discovery
5. VC funding increased in third quarter with shining life sciences
6. Wisconsin-based Third Wave reports increased revenue for 2003, fourth quarter
7. Alfalight Gets $3.8M From DARPA - Funding has increased to $8.5 Million
8. Brinkmann/Eppendorf SOP Standard Operating Procedure for Pipettes
9. Sonic Foundry posts explosive growth, though still operating at a loss
10. Fiserv reports $113.5 million in Q1 profit
11. Re-engineering our economy to be sustainable and profitable
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/2/2016)... , May 2, 2016 ... that its technology partner Mannin Research Inc. will be ... (ARVO), which takes place from May 1-5, 2016 in ... will be meeting with its vendors and research partners. ... business development goals and other collaborative opportunities for the ...
(Date:5/2/2016)... ... May 02, 2016 , ... StarNet Communications Corp, ( http://www.starnet.com/ ... addition of three Secure Remote Desktop modules to its flagship X-Win32 PC X server. ... and Unix servers to the user’s PC over encrypted SSH. , Traditionally, users of ...
(Date:4/29/2016)... , ... April 30, 2016 , ... The MIT bioLogic ... design, the bioLogic team explored how bacterial properties can be applied to fabric and ... Natto bacteria, which move in response to humidity change. The team harvested Natto cells ...
(Date:4/29/2016)... ... April 29, 2016 , ... ... used in spinal surgical procedures, today announced the completion of a significant transaction ... for current and future customers and partners. Kohlberg & Company, L.L.C. (“Kohlberg”), ...
Breaking Biology Technology:
(Date:3/22/2016)... , March 22, 2016 ... research report "Electronic Sensors Market for Consumer Industry by ... & Others), Application (Communication & IT, Entertainment, ... - Global Forecast to 2022", published by ... is expected to reach USD 26.76 Billion ...
(Date:3/17/2016)... , March 17, 2016 ABI ... intelligence, forecasts the global biometrics market will reach ... impressive 118% increase from 2015. Consumer electronics, particularly ... embedded fingerprint sensors anticipated to reach two billion ... Dimitrios Pavlakis , Research Analyst at ...
(Date:3/14/2016)... March 14, 2016 http://www.apimages.com ... --> - Renvoi : image disponible via ... --> --> DERMALOG, le ... de nouveaux lecteurs d,empreintes digitales pour l,enregistrement des ... sera utilisé pour produire des cartes d,identité aux ...
Breaking Biology News(10 mins):